Navigation Links
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
Date:3/26/2008

>Interest income 887,636 172,873

Loss before income taxes (4,139,493) (2,729,454)

Provision for income taxes - -

Net loss $(4,139,493) $(2,729,454)

Net loss per share - basic and diluted $ (0.33) $ (0.36)

Weighted average shares outstanding

- basic and diluted 12,525,405 7,687,630

CATALYST PHARMACEUTICAL PARTNERS, INC.

(a development stage company)

CONDENSED BALANCE SHEETS

December 31,

2007 2006

ASSETS

Current assets:

Cash and cash equivalents $15,943,896 $20,434,702

Interest receivable 63,709 85,787

Prepaid expenses 524,081 67,333

Total current assets 16,531,686 20,587,822

Property and equipment, net 127,788 20,157

Deposits 20,448 11,500

Total assets $16,679,922 $20,619,479

LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities:

Accounts payable $219,866 $448,072

Accrued expenses and other liabilities 83,419 324,774

Total current liabilities 303,285 772,846

Accrued expenses and other liabilities,

non current 53,880 -

Total liabilities 357,165 772,846'/>"/>

SOURCE Catalyst Pharmaceutical Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
(Date:8/21/2014)... , Aug. 21, 2014  Henry Schein, Inc. (NASDAQ: ... products and services to office-based dental, animal health and medical ... investor conferences in September: , September 4, 2014 ... , NY at 12:50 p.m. ET , September 8, ... New York , NY at 1:25 p.m. ET ...
(Date:8/21/2014)... 21, 2014  Armada Health Care (Armada), the ... is pleased to announce an agreement with Aurora ... of innovative specialty pharmacy patient program offerings. The ... management services to specialty patients via Armada,s proprietary ... Aurora will use the OTM platform as its ...
Breaking Medicine Technology:BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4Henry Schein To Present At Two Investor Conferences In September 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3
... 23 May 2007 - The antidepressant duloxetine,hydrochloride was ... who did not respond, or responded only,partially, to ... of whether those patients were,switched from an SSRI ... presented today at the American Psychiatric,Association’s 160 th ...
... /PRNewswire/ -- With enormous,investments and the success ... need to develop effective strategies for,communicating clinical ... planning and execution will gain a significant,advantage ... and consulting firm Best Practices, LLC,successful companies ...
Cached Medicine Technology:In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 2In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 3In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 4In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 5In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 6In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 7In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 8In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 9Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 2Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 3
(Date:8/22/2014)... (PRWEB) August 22, 2014 ItsHot.com, a ... now offering 60-80% off on its range of beautiful ... the purchase of Gold Hearts 14K White Rose Gold ... a discount of 77%. Previously priced at $3,715.00, ... $859.00. The item code of this mesmerizing pendant embedded ...
(Date:8/22/2014)... August 22, 2014 Key West Health ... experts revealed their much anticipated study results of the ... today and released an accompanying infographic on their website. ... can have a major impact on the skin and ... and more. , When asked how they determined the ...
(Date:8/22/2014)... “Dr. Luciana Show – Aging and Falling” ... Luciana, is finding it challenging to stay on top of ... of hundreds of students, so the editing of the episodes ... completed, and she recently entered it into the festival circuit. ... her husband, actor/screenwriter Gregory Graham , the aging and ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Until now, those ... standard crutches or walkers to keep mobile. Thanks to an ... made much more effective. , He developed a prototype for ... an injured leg or foot but provide comfort and reduce ... to different heights, it is also convenient and easy to ...
(Date:8/22/2014)... August 22, 2014 Braverman Eye Center ... Fort Lauderdale at the most affordable fee. They are ... through their advanced Lasik treatments. LASIK is a highly ... Braverman Eye Center has been delivering successful LASIK solutions ... a glasses-free and contact lenses-free life with the help ...
Breaking Medicine News(10 mins):Health News:ItsHot.com Now Offers 60-80% Discount on its Striking Collection of Diamond Heart Pendants 2Health News:Key West Health & Beauty Announces The 12 Best & Worst U.S. Cities For Skin Study 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Braverman Eye Center Now Offers Lasik Treatment in Fort Lauderdale at the Most Affordable Fee 2
... Tenn., Feb. 13 Two laptop computers,are missing ... The dual-password protected laptops were used on ... Lifeblood,s blood,donors, including names, contact information, blood type, ... The organization is notifying all of the ...
... Corporation,(NYSE: SYK ) today announced that its Board ... $750 million of its common stock. Purchases may,be made ... privately negotiated,transactions or otherwise. The manner, timing and amount ... based on their evaluation of,market conditions, stock price and ...
... can lead to higher levels of severe post-natal depression (PND) and ... published in the February issue of Journal of Clinical Nursing. , ... Universite Nancy 2, France, found that just under a third of ... had PND. , Nine per cent of the women in ...
... Sun Busters(R), the swim,wear line for children that has ... protection now sports a new feature -- The Skin ... proud,to announce that they have met the high standards ... of 50+. UPF is a similar concept to SPF;,however ...
... Scientists in Switzerland are uncovering new clues about how cancer ... by studying stem cells, blank cells that have the potential ... scientists in UK have made a breakthrough in understanding the ... lymphoblastic leukaemia (ALL). The research should lead to less aggressive ...
... Procter & Gamble Company,(NYSE: PG ) today announced the following organizational ... will retire on June 1, 2008 after ... deputy general counsel, will succeed Mr. Johnson ... vice president - finance and accounting, global ...
Cached Medicine News:Health News:Two Laptop Computers Missing From Lifeblood's Main Office 2Health News:Male births are more likely to reduce quality of life and increase severe post-natal depression 2Health News:Male births are more likely to reduce quality of life and increase severe post-natal depression 3Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 3Health News:Stem cells give clues to understanding cancer and make breakthrough in childhood leukaemia 2Health News:Stem cells give clues to understanding cancer and make breakthrough in childhood leukaemia 3Health News:Procter & Gamble Announces Organizational Changes 2
Infusion Cannula, 2.0mm....
Subretinal Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
Medicine Products: